S 501 · 111th Congress 2009โ€“2011, ended

Fair Prescription Drug Competition Act

Latest action · Feb 26, 2009 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedFeb 26, 2009
  2. Passed SenateNot reached
  3. Passed HouseNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Fair Prescription Drug Competition Act - Amends the Federal Food, Drug, and Cosmetic Act to prohibit a holder of a new, approved drug application from commencing to manufacture, market, sell, or distribute a generic version of such drug from the time of the receipt of notice from the generic manufacturer that an abbreviated new drug application has been submitted for approval until the expiration or forfeiture of the exclusivity period granted to the generic manufacturer.

Cosponsors 7

Members who signed on, in the order they did. Signatures ran from Feb 26, 2009 to Mar 3, 2009; 5 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
D-NYCharles E. SchumerOriginalFeb 26, 2009
D-HIDaniel K. InouyeOriginalFeb 26, 2009
D-WIHerb KohlOriginalFeb 26, 2009
D-VTPatrick J. LeahyOriginalFeb 26, 2009
D-OHSherrod BrownOriginalFeb 26, 2009
D-NHJeanne ShaheenFeb 27, 2009
D-MIDebbie StabenowMar 3, 2009

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
SenateHealth, Education, Labor, and Pensions Committee
Referred Feb 26, 2009

Actions 3

Everything that happened, newest first.

  1. Feb 26, 2009Introduced in Senate
  2. Feb 26, 2009Sponsor introductory remarks on measure. (CR S2569-2570)
  3. Feb 26, 2009Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

In the Congressional Record 1

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
SenateDebate and remarks S2569John D. Rockefeller IV D-WVFeb 26, 2009

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Short Titles as Introduced
Fair Prescription Drug Competition Act

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Feb 26, 2009Introduced in Senate

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.